These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 6420604)

  • 1. [Therapeutic failure in the application of rifampin (RFP): evaluation and management].
    Yamazaki M
    Kekkaku; 1983 Sep; 58(9):498-501. PubMed ID: 6420604
    [No Abstract]   [Full Text] [Related]  

  • 2. [Therapeutic effects of treatment with RFP on previously treated cases of pulmonary tuberculosis (author's transl)].
    Sakurai H; Watanabe Y; Yamanaka M; Moriguchi T; Fujii K; Uenoyama T
    Kekkaku; 1980 Nov; 55(11):485-91. PubMed ID: 6780716
    [No Abstract]   [Full Text] [Related]  

  • 3. [Investigation on failures in the treatment of pulmonary tuberculosis with rifampicin. Tuberculosis Research Committee. RYOKEN].
    Kekkaku; 1984 Feb; 59(2):91-104. PubMed ID: 6431172
    [No Abstract]   [Full Text] [Related]  

  • 4. [Rifampicin in the treatment of patients with chronic destructive tuberculosis complicated by drug intolerance and Mycobacterium drug resistance].
    Adamovich VN; Kolomytseva OS; Gur'ian IE
    Vrach Delo; 1975 Jan; (1):95-9. PubMed ID: 806177
    [No Abstract]   [Full Text] [Related]  

  • 5. Rifampicin in the retreatment and original treatment of advanced pulmonary tuberculosis.
    Gyselen A
    Bull Int Union Tuberc; 1970 Jun; 43():60-3. PubMed ID: 4987555
    [No Abstract]   [Full Text] [Related]  

  • 6. [Monotherapy of chronic pulmonary tuberculosis using Rimactan. Report on a 3-month-long therapeutic series].
    Hofmann F
    Schweiz Med Wochenschr; 1968 Sep; 98(36):1363-7. PubMed ID: 4971389
    [No Abstract]   [Full Text] [Related]  

  • 7. [Clinical studies on the bacterial resistance to rifampicin].
    Sakurai H; Inoue I; Yamagami K
    Kekkaku; 1972 Dec; 47(12):475-9. PubMed ID: 4631478
    [No Abstract]   [Full Text] [Related]  

  • 8. [Changes in the incidence of microscopically positive findings along with negative culture of M. tuberculosis in patients treated with rifampicin].
    Popovic I; Begovic N
    Plucne Bolesti Tuberk; 1975; 27(1-2):47-52. PubMed ID: 808808
    [No Abstract]   [Full Text] [Related]  

  • 9. Experimental and clinical studies of rifampicin in tuberculosis.
    Konno K; Oizumi K; Hayashi I; Oka S
    Sci Rep Res Inst Tohoku Univ Med; 1970 Dec; 17(3):110-20. PubMed ID: 5004309
    [No Abstract]   [Full Text] [Related]  

  • 10. [Studies on the problems of resistance to antituberculous drugs. II--1. Clinically applicable criteria of drug-resistance to rifampicin].
    Baba H
    Kekkaku; 1994 Jun; 69(6):387-96. PubMed ID: 8041057
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Dynamics of rifampicin and ethambutol resistance of strains of Koch bacilli isolated from patients with pulmonary tuberculosis 1973-1981].
    Ionescu C; Timoşca S; Petreanu V; Petreanu C; Georgescu M; Martinescu T
    Rev Ig Bacteriol Virusol Parazitol Epidemiol Pneumoftiziol Pneumoftiziol; 1982; 31(4):315-20. PubMed ID: 6304845
    [No Abstract]   [Full Text] [Related]  

  • 12. [The clinical significance of the critical drug concentration of rifampicin. Report 2. Clinical investigation: the emergence and reversion of resistance (author's transl)].
    Baba H; Azuma Y
    Kekkaku; 1976 Jan; 51(1):7-12. PubMed ID: 815710
    [No Abstract]   [Full Text] [Related]  

  • 13. [The sensitivity of Mycobacterium tuberculosis to rifampicin and its clinical effectiveness (author's transl)].
    Chen HL
    Zhonghua Jie He He Hu Xi Xi Ji Bing Za Zhi; 1980 Feb; 3(2):104-5. PubMed ID: 6774865
    [No Abstract]   [Full Text] [Related]  

  • 14. Short-course treatment regimens for patients with tuberculosis.
    Dutt AK; Stead WW
    Arch Intern Med; 1980 Jun; 140(6):827-9. PubMed ID: 6770770
    [No Abstract]   [Full Text] [Related]  

  • 15. [Drug resistance system of Mycobacterium tuberculosis to RFP].
    Tsukamura M; Tamura M
    Kekkaku; 1974 Mar; 49(3):83-4. PubMed ID: 4210875
    [No Abstract]   [Full Text] [Related]  

  • 16. The antituberculous activity of rifamycin SV.
    Nitti V
    Helv Med Acta; 1965 Dec; 32(6):603-24. PubMed ID: 4958120
    [No Abstract]   [Full Text] [Related]  

  • 17. [Anti-mycobacterial activity of rifampicin].
    Gialdroni Grassi G
    G Ital Mal Torace; 1971; 25(2):77-88. PubMed ID: 5003253
    [No Abstract]   [Full Text] [Related]  

  • 18. [An investigation on multiple drug resistance of the rifampin resistant strains of Mycobacterium tuberculosis].
    Kuang T; Jin G; Song P; Li W; Wang Z
    Wei Sheng Wu Xue Bao; 1998 Apr; 38(2):152-4. PubMed ID: 12549378
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Rapid detection of Mycobacterium tuberculosis resistance to rifampin using DNA chip].
    Jing F; Hu Z; Sun Y
    Zhonghua Jie He He Hu Xi Za Zhi; 2001 Sep; 24(9):551-4. PubMed ID: 11758172
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Rapid prediction of rifampin susceptibility of Mycobacterium tuberculosis].
    Rinder H
    Pneumologie; 1998 Feb; 52(2):91-2. PubMed ID: 9557056
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.